http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-27944-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
| filingDate | 2003-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_609ff0b07fa84f597d7ee3187e4a8c48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f232fbf00915b9947f2ff61e21394f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc7a197df19487472f5319b8b44cf5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c770e825d9e798d99ced86379c0f71a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be8e2177a68a7e47118af226482df630 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c3bfe7e25b6337e723a22e2895c7ebf |
| publicationDate | 2004-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UY-27944-A1 |
| titleOfInvention | COMBINATION THERAPY FOR HYPERPROLIFERATIVE DISEASES |
| abstract | Pharmaceutical compositions containing: A therapeutically effective amount of a taxane derivative, a platinum coordination complex selected from the group consisting of carboplatin, tetraplatin and topotecan, a nucleoside analog compound selected from the group consisting of gencitabine hydrochloride and 5- FU, an anthracycline, a topoisomerase inhibitor selected from the group consisting of etoposide, teniposide, ansacrine, topotecan and Camptosar R, an aromatase inhibitor A therapeutically effective amount of an isothiazole derivative. Optionally an antihypertensive agent: and methods of treating hyperproliferative diseases in mammals. |
| priorityDate | 2003-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.